Lataa...
Changes in the Multiple Sclerosis Treatment Paradigm. What Do We Do Now and What Were We Doing Before?
BACKGROUND AND PURPOSE: The number of disease-modifying drugs (DMDs) available for treating relapsing-remitting multiple sclerosis is increasing. Numerous drugs have been approved since 2010 in South America, which has increased the complexity of the treatment algorithm. The aim of this study was to...
Tallennettuna:
| Julkaisussa: | J Clin Neurol |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Korean Neurological Association
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6172498/ https://ncbi.nlm.nih.gov/pubmed/30198224 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3988/jcn.2018.14.4.487 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|